Lyrfigtu (lirafugratinib), a once-daily pill, is for previously treated cholangiocarcinoma with an FGFR2 fusion or ...

Researchers developed a urine test that detects bladder cancer, predicts which patients will benefit from immunotherapy ...

T-797 enables tumor-cell killing in a human relevant model of checkpoint inhibitor–resistant colorectal cancer liver metastasesNative and ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and ...

AI-enabled digital pathology analysis shows aglatimagene significantly increased lymphocyte infiltration and immune engagement with tumor cells ...

Deep inside liver tumors, communities of bacteria appear to be quietly shaping whether the most aggressive forms of ...

One of the most frustrating realities in liver cancer treatment is that even after a seemingly successful surgical resection, ...

Open-source oncology tools span patient-facing trackers and explainers, genomics-to-therapy ranking systems, and LLMs ...

Ovarian cystic neoplasms are ovarian tumors that have cyst-like qualities. They can include epithelial ovarian tumors and germ cell tumors called teratomas. Ovarian cystic neoplasms can be benign, ...

BPDCN is an aggressive type of blood cancer that originates from plasmacytoid dendritic cells (pDCs), a component of the immune system that produces type 1 interferon cytokines. These cytokines help ...

HER-2-negative advanced breast cancer experienced significantly improved progression-free survival (PFS) when treated with an ...